Organon's SWOT analysis: women's health leader faces biosimilar growth, LOE challenges
Organon & Co. (NYSE:OGN), a global healthcare company spun off from Merck (NSE:PROR) in 2021, has established itself as a leader in women's health while expanding its presence in biosimilars and ...
Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?
We recently published a list of 10 Most Oversold S&P 500 Stocks in 2024. In this article, we are going to take a look at ...
https//insights.som.yale.edu8d
What Investors Are Missing about Pfizer and Merck
Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...
Is Merck & Co., Inc. (MRK) the Best Dividend Stock According to Wall Street Analysts?
We recently compiled a list of the 10 Best Dow Jones Dividend Stocks According to Wall Street Analysts. In this article, we ...
Analysts Defend Merck Amid Investor Concerns Over Weak Guidance
Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of foreign exchange, ...
NBC 10 Philadelphia14d
Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations. The company said that sales range reflects a decision to halt shipments of Gardasil ...